Lawyers who deposed top company officials in a civil case say they declined to answer questions about their failure to warn American hospitals of infection risks. Industry giant Olympus also is the subject of a criminal probe.
Small manufacturers are betting that disposable medical scopes will slash the risk of infection during procedures. Some doctors are skeptical of the cheaper models.
The federal agency took 14 months to warn the public about the potential for infections. Officials say they acted as fast as they could.
The effect of “repeal and replace” could have greatest consequences for hospitals. They accepted lower federal funding under the law because their uncompensated care was expected to fall as more people became insured.
The company’s CEO also dismisses Trump’s notion of selling insurance plans across state lines, calling it ‘perplexing.’
Uninsured Californians could more than double to 7.5 million if Affordable Care Act is repealed.
California tiene mucho que perder si el presidente electo Donald Trump y el Congreso liderado por republicanos cumplen con su promesa de campaña de revocar el Obamacare.
The agency found several prominent facilities had not followed rules on reporting incidents in which patients were harmed.
Other insurers complain that Blue Cross Blue Shield plans have bloated overhead costs and reap too much from the Obamacare risk-adjustment fund, paid for by insurers. The companies deny it.
The nation’s largest insurer and the state’s university health system intend to offer a health plan option to self-funded employers in California and pursue research drawing upon a huge reservoir of patient data.
Such medications account for more than a quarter of the state agency’s $2.1 billion in pharmacy costs.
California Insurance Commissioner Dave Jones says a publicly run health plan would bolster competition in the state. But some question whether it would lower premiums.
Consumers Union says Anthem Inc. and Blue Shield of California may be exploiting furor over prescription drug prices. State regulators are looking into the issue.
In a small study, Minnesota researchers found that the infant drops used to increase visibility during procedures may create a “perfect habitat” for bacteria and make scopes harder to clean.
Two Los Angeles area patients alleged a prominent UCLA spine surgeon harmed them by using Medtronic devices in experimental ways without their consent and failing to disclose his financial ties to the company. Both UCLA and Medtronic deny wrongdoing.
U.S. Rep. Ted Lieu (D-Calif.) renews his call for tightened laws that would force manufacturers to notify the Food and Drug Administration when they issue safety warnings in other countries related to the design and cleaning of their devices.
Newly released court documents show that after Tokyo-based Olympus Corp. alerted customers in Europe in 2013, it told its U.S. operation not to warn U.S. doctors and hospitals. Since then, at least 35 patients have died after being sickened in outbreaks.
A double-digit increase, which follows two years of moderate rate hikes, is likely to resonate across the country in debate over Obamacare.
Aerospace giant’s Southern California employees will have access to MemorialCare’s network of hospitals and clinics, in addition to UC Irvine Health and other providers.
Aetna to spend nearly $50 million on health initiatives, agrees to more rate review.